Spatial analysis of the neuronal density of aminergic brainstem nuclei in primary neurodegenerative and vascular dementia: A comparative immunocytochemical and quantitative study using a graph method

Analytical Cellular Pathology

Volumn 19, Issue 3-4, 1999, Pages 125-138

  Yang, Yan ^a   Beyreuther, Konrad ^a   Schmitt, Horst P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aminergic brain stem nuclei; Computer assisted; Image processing; Immunocytochemistry; Neurodegenerative diseases; Vascular dementia

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; FOREBRAIN; HUMAN; HUMAN CELL; IMAGE PROCESSING; IMMUNOCYTOCHEMISTRY; MALE; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NEUROMODULATION; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL;

EID: 0033498373     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/256382     Document Type: Article

References (103)

1. G.K. Aghajanian and C.P. VanderMaelen, Specific systems of the reticular core: serotonin, in: Handbook of Physiology, Vol. 4, Sec. I: Neurophysiology, V.B. Mountcastle, F.E. Bloom and S.R. Geiger, eds, Amer. Physiol. Soc., Bethesda, MD, USA, 1986, pp. 237-256.
2. M.A. Aletrino, O.J.M. Vogels, P.H.M.F. Van Domburg and H.J. Ten Donkelaar, Cell loss in the nucleus raphes dorsalis in the Alzheimer's disease, Neurobiol. Aging 13 (1992), 461-468.
3. S.E. Arnold and J.Q. Trojanowski, Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology, Schizophr. Bull. 22 (1996), 5-9.
4. K.G. Baker and G.M. Halliday, Ascending noradrenergic and serotoninergic systems in the human brain stem, in: Neurotransmitters in the Brain. Advances in Behavioral Biology, Vol. 43, D.J. Tracey, G. Paxinos and J. Stone, eds, Plenum Press, New York, 1995, pp. 155-172.
5. K.G. Barker, G.M. Halliday and I. Törk, Cytoarchitecture of the human dorsal raphe nucleus, J. Comp. Neurol. 301 (1990), 147-161.
6. K.G. Baker, G.M. Halliday, P. Halasz, J.P. Hornung, L.B. Geffen, R.G.H. Cotton and I. Törk, Cytoarchitecture of serotonin-sythesizing neurons in the pontine tegmentum of the human brain, Synapse 7 (1991), 301-320.
7. M.J. Ball and G.H. Murdoch, Neuropathological criteria for the diagnosis of Alzheimer's disease: are we really ready yet?, Neurobiol. Aging 18 (1997), S3-S12.
8. M.J. Ball, H. Braak, P. Coleman, D. Dickson, C. Duyckaerts et al., Consensus recom-mendations for the post-mortem diagnosis of Alzheimer's disease, Neurobiol. Aging 18(Suppl. 13S) (1997), 1-2.
9. C. Bancher, K. Jellinger, H. Lassmann, P. Fischer and F. Leblhuber, Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia, Eur. Arch. Psychiat. Clin. Neurosci. 246 (1996), 137-146.
10. H. Bernheimer and O. Hornykiewicz, Brain amines in Huntington's chorea, in: Advances in Neurology, Vol. 1: Huntington's Chorea, 1872-1973, A. Barbeau, T. Chase and G.W. Paulson, eds, Raven, New York, 1973, pp. 525-531.
11. K. Beyreuther and C.L. Masters, Tangle distanglement, Nature 383 (1996), 476-477.
12. K. Beyreuther and C.L. Masters, The ins and outs of amyloid-β, Nature 389 (1997), 677-678.
13. L.M. Bierer, P.R. Hof, D.P. Purohit, L. Carlin, J. Schmeidler, K.L. Davis and D.P. Perl, Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease, Arch. Neurol. 52 (1995), 81-88.
14. J. Blin, J.C. Baron, B. Dubois, C. Crouzel, M. Fiorelli, D. Attar-Levy, B. Pillon, D. Fournier, M. Vidailhet and Y. Agid, Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone, Brain 116(Pt 3) (1993), 497-510.
15. W. Bondareff and C. Mountjoy, Number of neurons in locus coeruleus in demented and non-demented patients: rapid estimation and correlated parameters, Neurobiol. Aging 7 (1986), 297-300.
16. W. Bondareff and C. Mountjoy, Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease, Alzheimer Dis. Assoc. Disord. 1 (1987), 256-262.
17. W. Bondareff, C.Q. Mountjoy, M. Roth, M.N. Rossor, L.L. Iversen and G.P. Reynolds, Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes, Arch. Gen. Psychiat. 44 (1987), 412-417.
18. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol. (Berl.) 82 (1991), 239-259.
19. V. Chan-Palay, Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease, in: Progress in Brain Research, Vol. 88, C.D. Barnes and O. Pompeiano, eds, 1991, pp. 625-630.
20. V. Chan-Palay and E. Asan, Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression, J. Comp. Neurol. 287 (1989), 373-392.
21. V. Chan-Palay, M. Höchli, B. Jentsch, B. Leonard and T. Zetzsche, Raphe serotonin neurons in the human brainstem in normal controls and patients with senile dementia of the Alzheimer type and Parkinson's disease: relationship to monoamine oxidase enzyme location, Dementia 3 (1992), 253-269.
22. W.J. Conover and R.L. Iman, Rank transformation as a bridge between parametric and nonparametric statistics, Amer. Statistician 35 (1981), 124-129.
23. B. Costall, A.M. Domeney, M.E. Kelly and R.J. Naylor, Influence of 5-HT on cognitive performance, in: Serotonin, CNS Receptors and Brain Function. Advances in the Biosciences, Vol. 85, P.R. Bradley, S.L. Handley, S.J. Cooper, B.J. Key, N.M. Barnes and J.H. Cooke, eds, Pergamon Press, Oxford, New York, 1992, pp. 147-164.
24. H. Cramer, Zur Neurochemie der Huntingtonschen Krankheit, in: Die Huntingtonsche Krankheit, G. Deuschl, G. Oepen and G. Wolff, eds, Springer, Berlin, 1988, pp. 128-139.
25. C.A. Curcio and T. Kemper, Nucleus raphe dorsalis in dementia of Alzheimer type: neurofibrillary changes and neuronal packing density, J. Neuropathol. Exp. Neurol. 43 (1984), 359-368.
26. D.W. Dickson, H.A. Crystal, C. Bevona, W. Horner, I. Vincent and P. Davies, Correlation of synaptic and pathological markers with cognition of the elderly, Neurobiol. Aging 16 (1995), 285-304.
27. P.L. DiPatre and B. Gelman, Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus, J. Neuropathol. Exp. Neurol. 56 (1997), 143-150.
28. C. Dussert, M. Rasigni, J. Palmari, G. Rasigni, A. Llebaria and F. Marty, Minimal spanning tree analysis of biological structures, J. Theoret. Biol. 125 (1987), 317-323.
29. C. Duyckaerts, J.-P. Brion, J.-J. Hauw and J. Flament-Durand, Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of Alzheimer type. Comparison of immunohistochemistry with a specific antibody and Bodian's protargol method, Acta Neuropathol. (Berl.) 73 (1987), 167-170.
30. A.J. Dwork, A.S. Susser, J. Keilp, C. Waniek, D. Liu, M. Kaufman, Z. Zemishlany and I. Prohovnik, Senile degeneration and cognitive impairment in chronic schizophrenia, Am. J. Psychiatry 155 (1998), 1536-1543.
31. S.J. Enna, J.P. Bennett, Jr., D.B. Bylund, S.H. Snyder, E.D. Bird and L.L. Iversen, Alterations of brain neurotransmitter receptor binding in Huntington's chorea. Brain Res. 116 (1976), 531-537.
32. S.J. Enna, E.D. Bird, J.P. Bennett, Jr., D.B. Bylund, H.J. Yamamura, L.L. Iversen and S.H. Snyder, Huntington's chorea. Changes in neurotransmitter receptors in the brain, New Engl. J. Med. 294 (1976), 1305-1309.
33. J.D. French, The reticular formation, in: Handbook of Physiology, Section 1, Neurophysiology, Vol. 2, J. Field, H.W. Magoun and V.E. Hall, eds, American Physiological Society, Washington DC, 1960, pp. 1281-1305.
34. D.C. German and C.L. White, Sparkman DR Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex, Neuroscience 21 (1987), 305-312.
35. M. Goedert, Tau protein and the neurofibrillary pathology of Alzheimer's disease, Ann. NY Acad. Sci. 777 (1996), 121-131.
36. M. Goedert, M.G. Spillantini and R.A. Crowsher, Tau proteins and neurofibrillary degeneration, Brain Pathol. 1 (1991), 279-286.
37. W.S.T. Griffin, J.G. Sheng, G.W. Roberts and R.E. Mrak, Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution, J. Neuropathol. Exp. Neurol. 54 (1995), 276-281.
38. G.M. Halliday and K.M. Culleǹ, Neurotransmitter changes in Alzheimer's disease, in: Neurotransmitters in the Human Brain. Advances in Behavioral Biology, Vol. 43, D.J. Tracey, G. Paxinos and J. Stone, eds, Plenum Press, New York, 1995, pp. 199-219.
39. G.M. Halliday, H.L. McCann, R. Pamphlett, W.S. Brooks, H. Creasey, E. McCusker, R.G.H. Cotton, G.A. Broe and C.G. Harper, Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation, Acta Neuropathol. 84 (1992), 638-650.
40. N. Ida, T. Hartmann, J. Pantel, J. Schröder, R. Zerfaß, H. Förstl, R. Sandbrink, C. Masters and K. Beyreuther, Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay, J. Biol. Chem. 271 (1996), 22908-22914.
41. K. Iqbal and I. Grundke-Iqbal, Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention. Ann. NY Acad. Sci. 777 (1996), 132-138.
42. E. Iseki, M. Matsushita, K. Kosaka, H. Kondo, T. Ishii and N. Amano, Distribution and morphology of brain stem plaques in Alzheimer's disease, Acta Neuropathol. (Berl.) 78 (1989), 131-136.
43. T. Ishii, Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia, Acta Neurophathol. (Berl.) 6 (1966), 181-187.
44. L.L. Iversen, M.N. Rossor, G.P. Reynolds, R. Hills, M. Roth, C.Q. Mountjoy, S.L. Foote, J.H. Morrison and F.E. Bloom, Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type, Neurosci. Lett. 39 (1983), 95-100.
45. B.L. Jacobs and C.A. Fornal, Serotonin and behavior. A general hypothesis, in: Psychopharmacology: The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, eds, Raven Press, New York, 1995, pp. 461-469.
46. K. Jellinger, Quantitative changes in some subcorticl nuclei in aging, Alzheimer's disease and Parkinson's disease, Neurobiol. Aging 8 (1987), 556-561.
47. K.A. Jellinger, Neuropathological staging of Alzheimer-related lesions: the challenge of establishing relations to age, Neurobiol. Aging 18 (1997), 369-375.
48. K.A. Jellinger and C. Bancher, Proposals for re-evaluation of current autopsy criteria for the diagnosis of Alzheimer's disease, Neurobiol. Aging 18 (1997), S55-S65.
49. K. Kayser and H. Stute, DNA content and minimum spanning tree in primary and metastatic adenocarcinoma of the lung, Acta Stereol. 8 (1989), 117-121.
50. K. Kayser, H. Stute and M. Tacke, Minimum spanning tree, integrated optical density and lymph node metastasis in bronchial carcinoma, Analyt. Cell. Pathol. 5 (1993), 225-234.
51. T.L. Kemper, M.B. Moss, D.L. Rosane and R.J. Killiany, Age-related neuronal loss in the nucleus centralis superior of the rhesus monkey, Acta Neuropathol. 94 (1997), 124-130.
52. H. Kolles, H. Ludt, G.H. Vince and W. Feiden, Application of minimal spanning trees in glioma grading - a CLIPPER program for the calculation and construction of minimal spanning trees, Computer Methods and Programs in Biomedicine 42 (1994), 201-206.
53. H. Lassmann, R. Weiler, R. Fischer, C. Bancher, K. Jellinger, E. Floor, W. Danielczyk, F. Seitelberger and H. Winkler, Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles, Neuroscience 46 (1992), 1-8.
54. B. Lavoie and A. Parent, Serotoninergic innervation of the thalamus in primate: an immunohistochemical study, J. Comp. Neurol. 312 (1991), 1-18.
55. H.W. Magoun, An ascending reticular activating system in the brain stem. Arch. Neurol. Psychiat. 67 (1952), 145-154.
56. R.S. el Mallakh, D.G. Kirch, R. Shelton, K.J. Fan, G. Pezeshkpour, S. Kanhouwa, R.J. Wyatt and J.E. Kelinman, The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia, J. Neuropsychiat. Clin. Neurosci. 3 (1991), 383-386.
57. L. Mamournas, M.A. Wilson, K.J. Axt and M.E. Molliver, Morphlogical aspects of serotonergic innervation, in: Serotonin, CNS Receptors and Brain Function. Advances in the Biosciences, Vol. 85, P.B. Bradley, S.L. Handley, S.J. Cooper, B.J. Key, N.M. Barnes and J.H. Coote, eds, Pergamon Press, Oxford, NY, USA, 1992, pp. 97-118.
58. D. Mann and P. Yates, Serotonin nerve cells in Alzheimer's disease, J. Neurol. Neurosurg. Psychiat. 46 (1983), 96-98.
59. D.M.A. Mann, P.O. Yates and J. Hawkes, The pathology of the human locus coeruleus, Clin. Neuropathol. 2 (1983), 1-7.
60. R. Marcelpoil and Y. Usson, Methods for the study of cellular sociology: Voronoi diagrams and parametrization of the spatial relationships, J. Theoret. Biol. 154 (1992), 359-369.
61. B. Marciniuk, D.M.A. Mann and P.O. Yates, The topography of cell loss from locus coeruleus in Alzheimer's disease, J. Neurol. Sci. 76 (1986), 335-345.
62. B. Marciniuk, D.M.A. Mann and P.O. Yates, Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged, Neurosci. Lett. 64 (1986), 247-252.
63. C.L. Masters and K. Beyreuther, Alzheimer's disease, Brit. Med. J. (BMJ) 316 (1998), 446-448.
64. A.C. McKee, K.S. Kosik and N.W. Kowall, Neuritic pathology and dementia in Alzheimer's disease, Ann. Neurol. 30 (1991), 156-165.
65. D.A. McCormick, Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamo-cortical activity, Progr. Neurobiol. 39 (1992), 337-338.
66. H.Y. Meltzer, Clozapine: mechanism of action in relation to ist clinical advantages, in: Recent Advances in Schizophrenia, A. Kales, C.N. Stefanis and J.A. Talbett, eds, Springer, New York, Berlin, Heidelberg, 1990, pp. 237-256.
67. C.C. Meltzer, G. Smith, S.T. DeKosky, B.G. Pollock, C.A. Mathis, R.Y. Moore, D.J. Kupfer and C.F. Reynolds, 3rd, Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging, Neuropsychopharmacology 18 (1998), 407-430.
68. J.H. Morrison and S.L. Foote, Noradrenergic and serotonergic innervation of cortical, thalamic, and tectal visual structures in old and new world monkeys, J. Comp. Neurol. 243 (1986), 117-118.
69. G.M. Murphy, Jr., K.O. Lim, M. Wieneke, W.G. Ellis, L.S. Forno, A.L. Hoff and T. Nordahl, No neuropathologic evidence for Alzheimer's disease among elderly schizophrenics, Biol. Psychiatry 43 (1998), 205-209.
70. Z. Nagy, M.M. Esiri, K.A. Jobst, J.K. Morris, E.M.-F. King, B. McDonald, S. Litchfield and A. Smith, Relative roles of plaques and tangles in dementia of Alzheimer's disease: correlation using three sets of neuropathological criteria, Dementia 6 (1995), 21-31.
71. R.L. Neve and N.K. Robakis, Alzheimer's disease: a reexamination of the amyloid hypothesis, Trends Neurosci. (TINS) 21 (1998), 15-19.
72. R. Nieuwenhuys, Cytoarchitectitre of the Brain, Springer, Berlin, Heidelberg, NY, 1985.
73. R. Nieuwenhuys, J. Voogel and Ch. Van Huijzen, The Human Central Nervous System. A Synopsis and Atlas, 3rd edn, Springer, Berlin, Heidelberg, NY, 1988.
74. J.F. O'Callaghan, An alternative definition for 'neighborhood of a point', IEEE Transact. Comput. 24 (1975), 1121-1125.
75. A. Nordberg, In vivo detection of neurotransmitter changes in Alzheimer's disease, Ann. NY Acad. Sci. 695 (1993), 27-33.
76. R.J. Oken and P.L. McGeer, Schizophrenia, Alzheimer's disease, and anti-inflammatory agents 22 (1996), 1-4.
77. J. Olszewski and D. Baxter, Cytoarchitecture of the Human Brain Stem, 2nd edn, Karger, Basel, 1982.
78. P. Powchik, M. Davidson, C.B. Nemeroff, V. Haroutunian, D. Purohit, M. Losonczy, G. Bissette, D. Perl, H. Ghanbari, B. Miller et al., Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment, Am. J. Psychiatry 150 (1993), 1726-1727.
79. R.C. Prim, Shortest connection networks and some generalizations, Bell Sys. Tech. J. 36 (1957), 1389-1401.
80. I. Prohovnik, A.J. Dwork, M.A. Kaufman and N. Willson, Alzheimer-type neuropathology in elderly schizophrenia, Schizophr. Bull. 19 (1993), 805-816.
81. D.P. Purohit, M. Davidson, D.P. Perl, P. Powchik, V.H. Haroutunian, L.M. Bierer, J. McCrystal, M. Losonczy and K.L. Davis, Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study, Biol. Psychiatry 33 (1993), 255-260.
82. D.P. Purohit, D.P. Perl, V.H. Haroutunian, P. Powchik, M. Davidson, J. McCrystal and K.L. Davis, Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases, Arch. Gen. Psychiatry 55 (1998), 205-211.
83. E. Ramon-Moliner and W.J.H. Nauta, The isodendritic core of the brain stem, J. Comp. Neurol. 126 (1966), 311-336.
84. T.W. Robbins and B.J. Everitt, Central norepinephrine neurons and behavior, in: Psychophamacology. The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, eds, Raven Press, New York, 1995, pp. 363-372.
85. F.J. Rohlf, A probabilistic minimum spanning tree algorithm, Information Processing Letters 7 (1978), 44-48.
86. R. Shi, M.E. Key and K.L. Kalra, Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections, J. Histochem. Cytochem. 39 (1991), 741-748.
87. G.G. Simpson, A. Roe and R.C. Lewontin, Quantitative Zoology, Chapter 11: Correlation and regression, Harcourt, Brace & World, New York, 1960, pp. 213-257.
88. H.A. Sneath and R.R. Sokal, Numerical Taxonomy, Section 5.7: Graphs and Trees, WH Freeman & Co, San Francisco, 1973, pp. 253-256.
89. S.H. Snyder, Drugs and the Brain, Scientific American Books Inc., New York, 1986.
90. P.C. Spector, J.H. Goodnight, J.P. Sall and W.S. Sarl, The GLM procedure, in: SAS® User's Guide: Statistics, 5th edn, SAS Institute Inc., Cary, NC, USA, 1985, pp. 433-506.
91. M. Tabaton, A. Schenone, P. Romagnoli, G.L. Mancardi, A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease, Acta Neuropathol. (Berl.) 68 (1985), 218-223.
92. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen and R. Katzman, Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol. 30 (1991), 572-580.
93. B.E. Tomlinson, D. Irving and G. Blessed, Cell loss in the locus coeruleus in senile dementia of Alzheimer type, J. Neurol. Sci. 49 (1981), 419-428.
94. R.J. Valentino and G.S. Aston-Jones, Physiological and anatomical determinants of locus coeruleus discharge: behavioral and clinical implications, in: Psychopharmacology. The Fourth Generation of Progress, F.E. Bloom and D.J. Kupfer, eds, Raven Press, New York, 1995, pp. 373-386.
95. A. Weidemann, G. König, D. Bunke, P. Fischer, J.M. Salbaum, C.L. Masters and K. Beyreuther, Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein, Cell 57 (1989), 115-126.
96. G. Wilcock, M. Esiri, D. Bowen and A. Hughes, The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type, J. Neurol. Neurosurg. Psychiat. 51 (1988), 842-849.
97. D. Wyper, J. Owens, D. Brown, J. Patterson, W. Watson, R. Hunter and J. McCulloch, Abnormalities in cerebral muscarinic acetylcholine receptors measured in vivo with SPECT in patients with Alzheime;r's disease, Neurobiol. Aging 13 (Suppl. 1S) (1992), 23.
98. M. Yamada and P. Mehraein, Verteilungsmuster der senilen Veränderungen in den Hirnstammkemen, Folia Psychiat. Neurol. Japon 31 (1977), 219-224.
99. T. Yamamoto and A. Hirano, Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tanges and loss of large neurons, Ann. Neurol. 17 (1985), 573-577.
100. Y. Yang, H.P. Schmitt, G. Multhaup and K. Beyreuther, Microwave enhancement of β/A4 amyloid precursor protein (APP) and β/A4 amyloid peptide (AP) immunoreactivity in formalin-fixed and paraffin-embedded neural tissues of Alzheimer disease and various CNS disorders, Clin. Neuropathol. 14 (1995), 296 (Abstr.).
101. C.T. Zahn, Graph-theoretical methods for detecting and describing gestalt clusters, IEEE Transact. Comput. 20 (1971), 68-86.
102. R.M. Zweig, C.A. Ross, J.C. Hedreen, C. Steele, J.E. Cardillo, R.J. Whitehouse, M.F. Folstein and D. Price, The neuropathology of aminergic nuclei in Alzheimer's disease, Ann. Neurol. 24 (1988), 233-242.
103. R.M. Zweig, C.A. Ross, J.C. Hedreen, C. Steele, J.E. Cardillo, P.J. Whitehouse, M.F. Folstein and D.L. Price, Neuropathology of aminergic nuclei in Alzheimer's disease, Prog. Clin. Bio. Res. 317 (1989), 353-365.